RedShiftBio

RedShiftBio is located in Burlington, United States on 131 Middlesex Turnpike. RedShiftBio is rated 5 out of 5 in the category biotechnology company in United States. RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. Our origins are outside of the Life Sciences, but we are fast learners and listen closely to the needs of our customers. Being outsiders allowed us to see how new technologies from other fields could be combined to better solve problems within the Life Sciences. We developed our Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications, we started anew, and developed MMS from the ground up specifically with the protein scientist in mind. In 2015, in response to the unique capabilities and potential of MMS, we pivoted our spectroscopy business to focus entirely on bringing innovative analytical solutions to the protein scientist. And so we are changing, too. Our RedShiftBio team now includes talented Life Science veterans, protein scientists and instrumentation engineers. We are financially backed by venture capitalists and Waters Corporation, a leading provider of analytical instrumentation for the life sciences with annual sales of over $2 billion. At RedShiftBio, we develop tools to help protein scientist see more clearly. And that’s definitely change for the better.